What Can Machine Learning Approaches in Genomics Tell Us about the Molecular Basis of Amyotrophic Lateral Sclerosis?
暂无分享,去创建一个
George Giannakopoulos | Christina Vasilopoulou | Andrew P Morris | Stephanie Duguez | William Duddy | A. Morris | George Giannakopoulos | S. Duguez | W. Duddy | C. Vasilopoulou | A. Morris | A. Morris
[1] John Q. Trojanowski,et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS , 2010, Nature.
[2] J. Friedman. Special Invited Paper-Additive logistic regression: A statistical view of boosting , 2000 .
[3] C. Combs,et al. Microglial Phenotype Is Regulated by Activity of the Transcription Factor, NFAT (Nuclear Factor of Activated T Cells) , 2010, The Journal of Neuroscience.
[4] J. Rowe,et al. Genetic screening in sporadic ALS and FTD , 2017, Journal of Neurology, Neurosurgery, and Psychiatry.
[5] Annelot M. Dekker,et al. Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis , 2017 .
[6] J. Qin,et al. The NEK1 interactor, C21ORF2, is required for efficient DNA damage repair. , 2015, Acta biochimica et biophysica Sinica.
[7] F. Dudbridge. Power and Predictive Accuracy of Polygenic Risk Scores , 2013, PLoS genetics.
[8] Ole Winther,et al. JASPAR, the open access database of transcription factor-binding profiles: new content and tools in the 2008 update , 2007, Nucleic Acids Res..
[9] T. Hortobágyi,et al. ALS mutant FUS disrupts nuclear localization and sequesters wild-type FUS within cytoplasmic stress granules , 2013, Human molecular genetics.
[10] Janel O. Johnson,et al. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study , 2012, The Lancet Neurology.
[11] G. de los Campos,et al. Can Deep Learning Improve Genomic Prediction of Complex Human Traits? , 2018, Genetics.
[12] J. Haines,et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.
[13] Cheng Soon Ong,et al. GWIS - model-free, fast and exhaustive search for epistatic interactions in case-control GWAS , 2013, BMC Genomics.
[14] Min Jae Lee,et al. The Proline/Arginine Dipeptide from Hexanucleotide Repeat Expanded C9ORF72 Inhibits the Proteasome , 2017, eNeuro.
[15] Shin J. Oh,et al. Mutant dynactin in motor neuron disease , 2003, Nature Genetics.
[16] Adriano Chiò,et al. State of play in amyotrophic lateral sclerosis genetics , 2013, Nature Neuroscience.
[17] A. Morris,et al. Data quality control in genetic case-control association studies , 2010, Nature Protocols.
[18] Marylyn D. Ritchie,et al. Imputation and quality control steps for combining multiple genome-wide datasets , 2014, Front. Genet..
[19] Shane J. Neph,et al. Systematic Localization of Common Disease-Associated Variation in Regulatory DNA , 2012, Science.
[20] S. Bohté,et al. Using the structure of genome data in the design of deep neural networks for predicting amyotrophic lateral sclerosis from genotype , 2019, bioRxiv.
[21] K. N. Chandrika,et al. Analysis of the human protein interactome and comparison with yeast, worm and fly interaction datasets , 2006, Nature Genetics.
[22] B. De Felice,et al. A miRNA signature in leukocytes from sporadic amyotrophic lateral sclerosis. , 2012, Gene.
[23] Luana Licata,et al. The MIntAct Project and Molecular Interaction Databases. , 2016, Methods in molecular biology.
[24] B. Traynor,et al. Genome-wide association reveals three SNPs associated with sporadic amyotrophic lateral sclerosis through a two-locus analysis , 2009, BMC Medical Genetics.
[25] Steffen Jung,et al. Control of microglial neurotoxicity by the fractalkine receptor , 2006, Nature Neuroscience.
[26] M. Swanson,et al. RNA mis-splicing in disease , 2015, Nature Reviews Genetics.
[27] C. Shaw,et al. Familial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal transport to reduce axonal mitochondria content. , 2007, Human molecular genetics.
[28] S. Cavallaro,et al. Omics-based exploration and functional validation of neurotrophic factors and histamine as therapeutic targets in ALS , 2020, Ageing Research Reviews.
[29] O. Hardiman,et al. Clustering of Neuropsychiatric Disease in First-Degree and Second-Degree Relatives of Patients With Amyotrophic Lateral Sclerosis , 2017, JAMA neurology.
[30] J. Marchini,et al. Genotype imputation for genome-wide association studies , 2010, Nature Reviews Genetics.
[31] R. Klein,et al. Successes of Genome-wide Association Studies , 2010, Cell.
[32] L. Martin,et al. Mitochondrial DNMT3A and DNA methylation in skeletal muscle and CNS of transgenic mouse models of ALS , 2013, Front. Cell. Neurosci..
[33] Sonja W. Scholz,et al. Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data , 2007, The Lancet Neurology.
[34] A. Chiò,et al. Projected increase in amyotrophic lateral sclerosis from 2015 to 2040 , 2016, Nature Communications.
[35] Orla Hardiman,et al. A genome-wide association study of sporadic ALS in a homogenous Irish population. , 2007, Human molecular genetics.
[36] D. Timmann,et al. Multisystemic SYNE1 ataxia: confirming the high frequency and extending the mutational and phenotypic spectrum. , 2016, Brain : a journal of neurology.
[37] Vijay Kumar,et al. Unraveling the Role of RNA Mediated Toxicity of C9orf72 Repeats in C9-FTD/ALS , 2017, Front. Neurosci..
[38] Andries T Marees,et al. A tutorial on conducting genome‐wide association studies: Quality control and statistical analysis , 2018, International journal of methods in psychiatric research.
[39] M. Collins,et al. TBK1: a new player in ALS linking autophagy and neuroinflammation , 2017, Molecular Brain.
[40] Núria Queralt-Rosinach,et al. DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants , 2016, Nucleic Acids Res..
[41] A. Chiò,et al. Global Epidemiology of Amyotrophic Lateral Sclerosis: A Systematic Review of the Published Literature , 2013, Neuroepidemiology.
[42] Jason H. Moore,et al. Chapter 11: Genome-Wide Association Studies , 2012, PLoS Comput. Biol..
[43] Elizabeth M. Smigielski,et al. dbSNP: the NCBI database of genetic variation , 2001, Nucleic Acids Res..
[44] J. Jakobsson,et al. TRIM28 and the control of transposable elements in the brain , 2019, Brain Research.
[45] Y. Kawahara,et al. TDP-43 promotes microRNA biogenesis as a component of the Drosha and Dicer complexes , 2012, Proceedings of the National Academy of Sciences.
[46] E. Lander,et al. On the allelic spectrum of human disease. , 2001, Trends in genetics : TIG.
[47] Robert H. Brown,et al. Decoding ALS: from genes to mechanism , 2016, Nature.
[48] K. Sirotkin,et al. The NCBI dbGaP database of genotypes and phenotypes , 2007, Nature Genetics.
[49] Min Kyung Sung,et al. Convolutional neural network model to predict causal risk factors that share complex regulatory features , 2019, bioRxiv.
[50] K. Van Steen,et al. The search for gene-gene interactions in genome-wide association studies: challenges in abundance of methods, practical considerations, and biological interpretation. , 2018, Annals of translational medicine.
[51] A. Al-Chalabi,et al. A Knowledge-Based Machine Learning Approach to Gene Prioritisation in Amyotrophic Lateral Sclerosis , 2020, Genes.
[52] S. Duguez,et al. Molecular and Cellular Mechanisms Affected in ALS , 2020, Journal of personalized medicine.
[53] Geoffrey E. Hinton,et al. Visualizing Data using t-SNE , 2008 .
[54] F. Dudbridge,et al. Estimation of significance thresholds for genomewide association scans , 2008, Genetic epidemiology.
[55] Susumu Goto,et al. The commonality of protein interaction networks determined in neurodegenerative disorders (NDDs) , 2007, Bioinform..
[56] Xiang Hu,et al. TNFAIP1 contributes to the neurotoxicity induced by Aβ25–35 in Neuro2a cells , 2016, BMC Neuroscience.
[57] Carlo Sidore,et al. Rare variant genotype imputation with thousands of study-specific whole-genome sequences: implications for cost-effective study designs , 2014, European Journal of Human Genetics.
[58] Hui Xiong,et al. K-Means-Based Consensus Clustering: A Unified View , 2015, IEEE Transactions on Knowledge and Data Engineering.
[59] T. Reich,et al. A perspective on epistasis: limits of models displaying no main effect. , 2002, American journal of human genetics.
[60] F. Dudbridge. Correction: Power and Predictive Accuracy of Polygenic Risk Scores , 2013, PLoS Genetics.
[61] Jason H. Moore,et al. Multifactor dimensionality reduction for graphics processing units enables genome-wide testing of epistasis in sporadic ALS , 2010, Bioinform..
[62] John W Griffin,et al. DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). , 2004, American journal of human genetics.
[63] Patricia B. Munroe,et al. Reaching the End-Game for GWAS: Machine Learning Approaches for the Prioritization of Complex Disease Loci , 2020, Frontiers in Genetics.
[64] Alan M. Kwong,et al. A reference panel of 64,976 haplotypes for genotype imputation , 2015, Nature Genetics.
[65] O. Hardiman,et al. Aggregation of neurologic and neuropsychiatric disease in amyotrophic lateral sclerosis kindreds: A population‐based case–control cohort study of familial and sporadic amyotrophic lateral sclerosis , 2013, Annals of neurology.
[66] J. H. Moore,et al. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. , 2001, American journal of human genetics.
[67] Ting Hu,et al. Epistasis, complexity, and multifactor dimensionality reduction. , 2013, Methods in molecular biology.
[68] M. Ritchie. Using Biological Knowledge to Uncover the Mystery in the Search for Epistasis in Genome‐Wide Association Studies , 2011, Annals of human genetics.
[69] Bilal Mirza,et al. Machine Learning and Integrative Analysis of Biomedical Big Data , 2019, Genes.
[70] Joris M. Mooij,et al. MAGMA: Generalized Gene-Set Analysis of GWAS Data , 2015, PLoS Comput. Biol..
[71] Claire Cardie,et al. Proceedings of the Eighteenth International Conference on Machine Learning, 2001, p. 577–584. Constrained K-means Clustering with Background Knowledge , 2022 .
[72] Frank W. Stearns. One Hundred Years of Pleiotropy: A Retrospective , 2010, Genetics.
[73] S. Duguez,et al. A Systematic Review of Genotype–Phenotype Correlation across Cohorts Having Causal Mutations of Different Genes in ALS , 2020, Journal of personalized medicine.
[74] Suzanna Lewis,et al. Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium , 2011, Briefings Bioinform..
[75] E. Beghi,et al. Prognostic factors in ALS: A critical review , 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[76] F. Benfenati,et al. Abnormal exocytotic release of glutamate in a mouse model of amyotrophic lateral sclerosis , 2011, Journal of neurochemistry.
[77] J. Lipski,et al. GluR2 AMPA Receptor Subunit Expression in Motoneurons at Low and High Risk for Degeneration in Amyotrophic Lateral Sclerosis , 2001, Experimental Neurology.
[78] A. Bjourson,et al. A Systematic Review of Suggested Molecular Strata, Biomarkers and Their Tissue Sources in ALS , 2019, Front. Neurol..
[79] A. Spiro,et al. Respiratory failure in amyotrophic lateral sclerosis. , 1984, New York state journal of medicine.
[80] J. Collinge,et al. ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B) , 2006, Neurology.
[81] R. Ransohoff,et al. The myeloid cells of the central nervous system parenchyma , 2010, Nature.
[82] Xiang Hu,et al. TNFAIP 1 contributes to the neurotoxicity induced by Aβ 25 – 35 in Neuro 2 a cells , 2016 .
[83] Jason H. Moore,et al. Gene ontology analysis of pairwise genetic associations in two genome-wide studies of sporadic ALS , 2012, BioData Mining.
[84] P. Andersen,et al. NEK1 loss-of-function mutation induces DNA damage accumulation in ALS patient-derived motoneurons. , 2018, Stem cell research.
[85] M. Vidal,et al. New insights into the function of Rab GTPases in the context of exosomal secretion , 2017, Small GTPases.
[86] D. Borchelt,et al. Messenger RNA Oxidation Occurs Early in Disease Pathogenesis and Promotes Motor Neuron Degeneration in ALS , 2008, PloS one.
[87] Min Kyung Sung,et al. Functional fine-mapping of noncoding risk variants in amyotrophic lateral sclerosis utilizing convolutional neural network , 2020, Scientific Reports.
[88] K. Borgwardt,et al. Machine Learning in Medicine , 2015, Mach. Learn. under Resour. Constraints Vol. 3.
[89] L. Foster,et al. CNS-derived extracellular vesicles from superoxide dismutase 1 (SOD1)G93A ALS mice originate from astrocytes and neurons and carry misfolded SOD1 , 2019, The Journal of Biological Chemistry.
[90] M. Marazita,et al. Genome-wide Association Studies , 2012, Journal of dental research.
[91] O. Hardiman,et al. Heritability of Amyotrophic Lateral Sclerosis: Insights From Disparate Numbers. , 2015, JAMA neurology.
[92] J. Rothstein,et al. Altered expression of the glutamate transporter EAAT2b in neurological disease , 2004, Annals of neurology.
[93] Ammar Al-Chalabi,et al. Clinical genetics of amyotrophic lateral sclerosis: what do we really know? , 2011, Nature Reviews Neurology.
[94] S. Raghav,et al. TRIM16 controls assembly and degradation of protein aggregates by modulating the p62‐NRF2 axis and autophagy , 2018, The EMBO journal.
[95] Amrita Chattopadhyay,et al. Gene-gene interaction: the curse of dimensionality. , 2019, Annals of translational medicine.
[96] M. Ruepp,et al. The emerging role of minor intron splicing in neurological disorders , 2018, Cell stress.
[97] Nam Jin Yoo,et al. Laminin gene LAMB4 is somatically mutated and expressionally altered in gastric and colorectal cancers , 2015, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[98] P. Andersen,et al. Current knowledge and recent insights into the genetic basis of amyotrophic lateral sclerosis , 2018, medizinische genetik.
[99] T. Cech,et al. FUS binds the CTD of RNA polymerase II and regulates its phosphorylation at Ser2. , 2012, Genes & development.
[100] E. Lander,et al. The mystery of missing heritability: Genetic interactions create phantom heritability , 2012, Proceedings of the National Academy of Sciences.
[101] Daniel Neil,et al. Applications of machine learning to diagnosis and treatment of neurodegenerative diseases , 2020, Nature Reviews Neurology.
[102] N. Wray,et al. Contrasting genetic architectures of schizophrenia and other complex diseases using fast variance components analysis , 2015, Nature Genetics.
[103] Peter Kraft,et al. Quality control and quality assurance in genotypic data for genome‐wide association studies , 2010, Genetic epidemiology.
[104] A. Ludolph,et al. Amyotrophic lateral sclerosis. , 2012, Current opinion in neurology.
[105] R. Myers. Huntington’s disease genetics , 2004, NeuroRX.
[106] J. MacQueen. Some methods for classification and analysis of multivariate observations , 1967 .
[107] Olubunmi Abel,et al. ALSoD: A user‐friendly online bioinformatics tool for amyotrophic lateral sclerosis genetics , 2012, Human mutation.
[108] I. Ferrer,et al. Amyotrophic lateral sclerosis, gene deregulation in the anterior horn of the spinal cord and frontal cortex area 8: implications in frontotemporal lobar degeneration , 2017, Aging.
[109] G. Ebers,et al. Epistasis , 2015, Methods in Molecular Biology.
[110] Lorne Zinman,et al. Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis , 2014, Nature Neuroscience.
[111] G. Rouleau,et al. Genetics of motor neuron disorders: new insights into pathogenic mechanisms , 2009, Nature Reviews Genetics.
[112] Yoav Freund,et al. A Short Introduction to Boosting , 1999 .
[113] W. Johnson,et al. Familial aggregation of amyotrophic lateral sclerosis, dementia, and Parkinson's disease , 1994, Neurology.
[114] Tudor Groza,et al. The Human Phenotype Ontology in 2017 , 2016, Nucleic Acids Res..
[115] Dimitrios Vitsios,et al. Mantis-ml: Disease-Agnostic Gene Prioritization from High-Throughput Genomic Screens by Stochastic Semi-supervised Learning , 2020, American journal of human genetics.
[116] Steve Epstein,et al. Identification of new susceptibility loci for type 2 diabetes and shared etiological pathways with coronary heart disease , 2017, Nature Genetics.
[117] Aberrant Regulation of DNA Methylation in Amyotrophic Lateral Sclerosis: A New Target of Disease Mechanisms , 2013, Neurotherapeutics.
[118] A. Singleton,et al. Repeat expansion in C9ORF72 in Alzheimer's disease. , 2012, The New England journal of medicine.
[119] J. Dubnau,et al. Transposable Elements in TDP-43-Mediated Neurodegenerative Disorders , 2012, PloS one.
[120] Leo Breiman,et al. Random Forests , 2001, Machine Learning.
[121] M. Marinkovich,et al. Bridging structure with function: structural, regulatory, and developmental role of laminins. , 2008, The international journal of biochemistry & cell biology.
[122] Quanshi Zhang,et al. Visual interpretability for deep learning: a survey , 2018, Frontiers of Information Technology & Electronic Engineering.
[123] Rafael C. Jimenez,et al. The MIntAct project—IntAct as a common curation platform for 11 molecular interaction databases , 2013, Nucleic Acids Res..
[124] S. Duguez,et al. Personalized Medicine and Molecular Interaction Networks in Amyotrophic Lateral Sclerosis (ALS): Current Knowledge , 2018, Journal of personalized medicine.
[125] O. Stegle,et al. Deep learning for computational biology , 2016, Molecular systems biology.
[126] F. Pasquier,et al. C9orf72 repeat expansions are a rare genetic cause of parkinsonism. , 2013, Brain : a journal of neurology.
[127] S. Elena,et al. The causes of epistasis , 2011, Proceedings of the Royal Society B: Biological Sciences.
[128] Deanna M. Church,et al. ClinVar: public archive of relationships among sequence variation and human phenotype , 2013, Nucleic Acids Res..
[129] Alexander E. Kel,et al. TRANSFAC®: transcriptional regulation, from patterns to profiles , 2003, Nucleic Acids Res..
[130] Helen E. Parkinson,et al. The new NHGRI-EBI Catalog of published genome-wide association studies (GWAS Catalog) , 2016, Nucleic Acids Res..
[131] C. Emiliani,et al. Lysosomal Exocytosis, Exosome Release and Secretory Autophagy: The Autophagic- and Endo-Lysosomal Systems Go Extracellular , 2020, International journal of molecular sciences.
[132] Timothy A. Miller,et al. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene in and for Therapeutic , 2018 .
[133] V. Meininger,et al. Glutamate levels in cerebrospinal fluid in amyotrophic lateral sclerosis: a reappraisal using a new HPLC method with coulometric detection in a large cohort of patients , 2002, Journal of the Neurological Sciences.
[134] M. Mesulam,et al. FUS Interacts with HSP60 to Promote Mitochondrial Damage , 2015, PLoS genetics.
[135] M. Ashburner,et al. Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.
[136] Bernhard E. Boser,et al. A training algorithm for optimal margin classifiers , 1992, COLT '92.
[137] Peter Langfelder,et al. Weighted gene co-expression network analysis of the peripheral blood from Amyotrophic Lateral Sclerosis patients , 2009, BMC Genomics.
[138] Raymond Walters,et al. Significant Locus and Metabolic Genetic Correlations Revealed in Genome-Wide Association Study of Anorexia Nervosa. , 2017, The American journal of psychiatry.
[139] R. Pochet,et al. Brain and spinal cord affected by amyotrophic lateral sclerosis induce differential growth factors expression in rat mesenchymal and neural stem cells , 2011, Neuropathology and applied neurobiology.
[140] Zina M. Ibrahim,et al. Knowledge graph prediction of unknown adverse drug reactions and validation in electronic health records , 2017, Scientific Reports.
[141] A. Al-Chalabi,et al. An estimate of amyotrophic lateral sclerosis heritability using twin data , 2010, Journal of Neurology, Neurosurgery & Psychiatry.
[142] Amina Adadi,et al. Peeking Inside the Black-Box: A Survey on Explainable Artificial Intelligence (XAI) , 2018, IEEE Access.
[143] Minoru Kanehisa,et al. KEGG: new perspectives on genomes, pathways, diseases and drugs , 2016, Nucleic Acids Res..
[144] J. Milbrandt,et al. Abnormal Microglia and Enhanced Inflammation-Related Gene Transcription in Mice with Conditional Deletion of Ctcf in Camk2a-Cre-Expressing Neurons , 2017, The Journal of Neuroscience.
[145] A. Chiò,et al. Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications , 2018, The Lancet Neurology.
[146] A. Al-Chalabi,et al. Gene discovery in amyotrophic lateral sclerosis: implications for clinical management , 2017, Nature Reviews Neurology.
[147] Naomi R. Wray,et al. Project MinE: study design and pilot analyses of a large-scale whole-genome sequencing study in amyotrophic lateral sclerosis , 2018, European Journal of Human Genetics.
[148] Ferat Sahin,et al. A survey on feature selection methods , 2014, Comput. Electr. Eng..
[149] Mendel's Principles of Heredity: a Defence Reports to the Evolution Committee of the Royal Society , 1902, Nature.
[150] C. Haley,et al. An Evolutionary Perspective on Epistasis and the Missing Heritability , 2013, PLoS genetics.
[151] O. Andreassen,et al. Selective Genetic Overlap Between Amyotrophic Lateral Sclerosis and Diseases of the Frontotemporal Dementia Spectrum , 2018, JAMA neurology.
[152] Y. Bossé,et al. Benefits and limitations of genome-wide association studies , 2019, Nature Reviews Genetics.
[153] Jean-Pierre Bouchard,et al. Replication study of MATR3 in familial and sporadic amyotrophic lateral sclerosis , 2016, Neurobiology of Aging.
[154] F. Sanz,et al. The DisGeNET knowledge platform for disease genomics: 2019 update , 2019, Nucleic Acids Res..
[155] Zhi-rui Zhou,et al. Genetic epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis , 2017, Journal of Neurology, Neurosurgery & Psychiatry.
[156] N. Shneider,et al. Antisense Proline-Arginine RAN Dipeptides Linked to C9ORF72-ALS/FTD Form Toxic Nuclear Aggregates that Initiate In Vitro and In Vivo Neuronal Death , 2014, Neuron.
[157] Lei Zhan,et al. LAMB3 mediates apoptotic, proliferative, invasive, and metastatic behaviors in pancreatic cancer by regulating the PI3K/Akt signaling pathway , 2019, Cell Death & Disease.
[158] Leland McInnes,et al. UMAP: Uniform Manifold Approximation and Projection , 2018, J. Open Source Softw..
[159] P. Andersen,et al. Changes in the Spinal Cord Proteome of an Amyotrophic Lateral Sclerosis Murine Model Determined by Differential In-gel Electrophoresis* , 2009, Molecular & Cellular Proteomics.